Modern medicine has brought huge health benefits. Now researchers want to go further.
Nature Outlook |
The future of medicine
Modern medicine is affording people longer and healthier lives. But researchers want to take improvements in health even further. With advances in gene editing, technology to overcome paralysis and efforts to address high drug costs, the future of medicine is bright.
This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.
Features and comment
Web searches, medical records and networks of local volunteers are enabling faster control of disease outbreaks.
Old drugs and new tricks keep researchers one step ahead of antibiotic resistance.
Gene editing is quietly revolutionizing the search for new drugs.
Technologies that restore movement and the sense of touch are helping people to overcome the physical effects of stroke and spinal-cord injury.
Innovative drugs have the potential to save lives worldwide — if they are affordable.
A more tolerant immune system could alleviate, or even prevent, autoimmune disorders such as type 1 diabetes and multiple sclerosis, as well as the rejection of transplanted organs.
The debilitating loss of muscle and strength that comes with age is being recognized as a disease that could be treated.
Altering the community of bacteria that live in the gut might help infants to thrive or even avoid conditions such as asthma and diabetes.
Although the benefits of reducing exposure to toxic chemicals are becoming clearer, the path from evidence to action is not straightforward.
A one-off injection to reduce the risk of cardiovascular disease is now a prospect thanks to advances in gene editing.
More from Nature Research
Anthony Letai proposes wider adoption of functional assays in efforts to match the right drug to the right patient and discusses why these assays might be complementary to existing genomics-based approaches.
Magistral drug preparation offers a model to circumvent many of the technological, regulatory and financial challenges that prevent provision of the right drug at the right time to the right patient.
In this Review, Cathomen and colleagues present the latest advances, including improvements in nuclease specificity and delivery, that will expedite the clinical translation of genome editing.
Emerging viral diseases present a huge and increasingly important global threat to public health systems. Graham and Sullivan discuss the challenges presented by emerging viral diseases and discuss how innovations in technology and policy can address this threat.
One strategy to counter the rise of antimicrobial resistance is the development of vaccines against resistant pathogens, preventing further infection and spread of antimicrobial resistance.
The recent publication of The Lancet Commission on pollution and health is a watershed moment for one of the greatest challenges to cardiovascular health. In this Comment article, we discuss the global burden of air pollution on cardiovascular health.
Diener et al. synthesize findings from psychology and economics on subjective well-being across cultures and identify outstanding questions, priorities for future research and pathways to policy implementation.